Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis.
- 1 October 2003
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 181 (5) , 259-265
- https://doi.org/10.1007/s00408-003-1028-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Significance of Vascular Endothelial Cell Growth Factor Up-Regulation Mediated via a Chymase-Angiotensin-Dependent Pathway during Angiogenesis in Hamster Sponge GranulomasThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Sarcoidosis: clinical update.2001
- The Gene Polymorphism of Tumor Necrosis Factor-β, But Not That of Tumor Necrosis Factor-α, Is Associated With the Prognosis of SarcoidosisChest, 2001
- Increased Serum Level of Vascular Endothelial Growth Factor in Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- CC Chemokine Receptor Gene Polymorphisms in Czech Patients with Pulmonary SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung diseaseJournal of Laboratory and Clinical Medicine, 2000
- Increased Expression of Vascular Endothelial Growth Factor in Pyogenic GranulomasActa Dermato-Venereologica, 1999
- Clinical courses and prognoses of pulmonary sarcoidosisCurrent Opinion in Pulmonary Medicine, 1999
- ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.1999
- The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patientsEuropean Respiratory Journal, 1999